Clin2
NCT05674552Possibly a fitRecruiting

Ketone drinks to treat hard-to-stop seizure emergencies

Status Epilepticus

Part of Brain & nervous system clinical trials.

This trial tests whether taking ketone esters (a special form of ketones) can help stop refractory generalized convulsive status epilepticus (a seizure emergency that is hard to control). If you qualify, the study team will check safety closely, especially your breathing, heart stability, and blood sugar/acid levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
50 people
Ages
1 year to 10 years
Study type
Interventional

Who can take part

  • You have refractory generalized convulsive status epilepticus (seizures that are not responding as expected).
  • You (or your legal representative) can give informed consent.
  • You have not had ketone products or started a ketogenic diet recently.
  • Your body is stable enough for treatment (heart/breathing are not unstable).
  • Your blood sugar and body acid levels are in a safe range, without dangerous imbalances.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06907173Recruiting· Phase 3
Ketamine for ongoing seizures in the ER

This trial tests if adding ketamine to standard care can stop seizures that continue after a first treatment. It is for people having a convulsive seizure lasting more than 5 minutes and who are still seizing in the emergency room.

Tucson, Arizona
NCT05851391Recruiting· Phase 2
Test drug treatment to stop hard-to-control seizures after cardiac arrest

This Phase 2 trial tests a medication strategy to stop “refractory status epilepticus,” a severe seizure condition that can happen after a cardiac arrest. It may help by reducing ongoing seizure activity after return of circulation in the ICU.

San Francisco, California
NCT03457831Recruiting
Check a treatment approach for prolonged seizure emergencies

This trial is for adults in the intensive care unit who are having seizures that last at least 5 minutes or keep coming back without fully recovering. It tests a study approach for managing a dangerous seizure emergency and may help doctors improve care for critically ill patients.

Angoulême
NCT07383779Not yet recruiting· Phase 3
Cooling vs normal temperature after tough-to-stop seizures

This trial tests whether lowering body temperature (targeted hypothermia) can help people recover better after a severe seizure that doesn't stop with usual medicines, compared to keeping body temperature normal. It's for adults on a breathing machine.

Boulogne-Billancourt
NCT04170491Recruiting
EEG monitoring for ongoing seizures in ICU

This trial studies whether using EEG (a brain-wave test) in the ICU can help guide care for people whose seizures keep going despite initial medicines. It may benefit patients with severe, difficult-to-stop status epilepticus by improving how doctors find and treat ongoing seizure activity.

London
NCT05670847Recruiting· Phase 2/Phase 3
Ketone drinks for drug-resistant epilepsy

This trial tests whether taking “ketone ester” supplements can reduce seizures in people with drug-resistant epilepsy. It may help by changing how the brain uses energy, but you must meet several safety and diet-related conditions.

Sohag

Hear when a new Status Epilepticus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.